These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36446643)
41. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification. Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753 [TBL] [Abstract][Full Text] [Related]
42. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS. Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867 [TBL] [Abstract][Full Text] [Related]
43. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Tarannum M; Vivero-Escoto JL Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679 [TBL] [Abstract][Full Text] [Related]
44. Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer. Pan J; Lai Y; Zhang S; Zhang H; Shan Y; Huang L; Wang F; Yu H; Xu L; Xu Z Adv Mater; 2023 Nov; 35(47):e2305798. PubMed ID: 37716012 [TBL] [Abstract][Full Text] [Related]
45. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402 [TBL] [Abstract][Full Text] [Related]
46. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920 [TBL] [Abstract][Full Text] [Related]
47. Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors. Vucetic M; Daher B; Cassim S; Parks S; Pouyssegur J Adv Exp Med Biol; 2021; 1301():7-24. PubMed ID: 34370285 [TBL] [Abstract][Full Text] [Related]
48. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System. Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364 [TBL] [Abstract][Full Text] [Related]
49. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464 [TBL] [Abstract][Full Text] [Related]
51. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573 [TBL] [Abstract][Full Text] [Related]
52. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy. Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301 [TBL] [Abstract][Full Text] [Related]
53. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411 [TBL] [Abstract][Full Text] [Related]
54. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352 [TBL] [Abstract][Full Text] [Related]
55. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036 [TBL] [Abstract][Full Text] [Related]
56. Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis. Shi H; Xiong L; Yan G; Du S; Liu J; Shi Y Front Mol Biosci; 2023; 10():1156062. PubMed ID: 37065442 [TBL] [Abstract][Full Text] [Related]
57. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874 [TBL] [Abstract][Full Text] [Related]
58. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer. Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203 [TBL] [Abstract][Full Text] [Related]
59. Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication. Guo X; Liu F; Deng J; Dai P; Qin Y; Li Z; Wang B; Fan A; Wang Z; Zhao Y ACS Nano; 2020 Nov; 14(11):14715-14730. PubMed ID: 33156626 [TBL] [Abstract][Full Text] [Related]